How about this: Let's say there is 2 billion OS ( which there isn't ). Share price is currently .007. That is a $14 million Market Cap. Sales are on track for $12 million this year. Should a Silicon Valley microarray company with high growth really have a Market Cap almost equal to its annual sales?